Protein Name |
Pfam ID |
Percentage of Identity (%) |
E value |
Mixed lineage kinase 1 (MAP3K9)
|
|
30.841 (99/321) |
1.91E-28 |
MST-1 protein kinase (STK4)
|
|
30.890 (59/191) |
1.23E-26 |
Serine/threonine-protein kinase 25 (STK25)
|
|
29.478 (79/268) |
1.75E-26 |
Serine/threonine-protein kinase 26 (STK26)
|
|
30.120 (75/249) |
1.75E-26 |
Serine/threonine-protein kinase 3 (STK3)
|
|
32.804 (62/189) |
2.64E-26 |
MAPK/ERK kinase kinase 1 (MAP3K1)
|
|
27.757 (73/263) |
5.81E-25 |
Serine/threonine-protein kinase 24 (STK24)
|
|
28.916 (72/249) |
2.81E-24 |
Doublecortin-like kinase 3 (DCLK3)
|
|
29.947 (56/187) |
2.75E-22 |
Serine/threonine-protein kinase ULK2 (ULK2)
|
|
31.818 (63/198) |
3.17E-22 |
Serine/threonine-protein kinase Nek3 (NEK3)
|
|
31.068 (64/206) |
5.39E-22 |
Fused homolog (STK36)
|
|
31.771 (61/192) |
1.24E-21 |
MEK kinase kinase 3 (MAP4K3)
|
|
30.806 (65/211) |
1.88E-21 |
Serine/threonine-protein kinase ULK1 (ULK1)
|
|
31.818 (63/198) |
2.09E-21 |
Serine/threonine-protein kinase 10 (STK10)
|
|
29.949 (59/197) |
2.20E-21 |
MEK kinase kinase 1 (MAP4K1)
|
|
29.798 (59/198) |
2.32E-21 |
Serine/threonine-protein kinase Nek5 (NEK5)
|
|
27.083 (52/192) |
8.51E-21 |
PAK-2 protein kinase (PAK2)
|
|
29.353 (59/201) |
1.18E-20 |
NIMA-related kinase 7 (NEK7)
|
|
27.407 (74/270) |
1.76E-20 |
Serine/threonine-protein kinase Nek4 (NEK4)
|
|
28.516 (73/256) |
2.37E-20 |
Cyclin-dependent kinase 1 (CDK1)
|
|
31.731 (66/208) |
2.61E-20 |
ERK activator kinase 1 (MEK1)
|
|
30.516 (65/213) |
3.04E-20 |
MAPK/ERK kinase kinase 4 (MAP3K4)
|
|
26.523 (74/279) |
3.04E-20 |
Mitogen-activated protein kinase kinase kinase kinase 5 (MAP4K5)
|
|
29.798 (59/198) |
3.21E-20 |
MAPK/ERK kinase kinase 2 (MAP3K2)
|
|
28.846 (75/260) |
3.60E-20 |
Unc-51 like kinase 3 (ULK3)
|
|
30.198 (61/202) |
3.81E-20 |
NIMA-related kinase 6 (NEK6)
|
|
27.615 (66/239) |
3.84E-20 |
Myosin light kinase (MYLK)
|
|
27.778 (65/234) |
3.96E-20 |
Calcium/calmodulin-dependent protein kinase type 1B (PNCK)
|
|
27.126 (67/247) |
4.33E-20 |
Cyclin-dependent kinase 3 (CDK3)
|
|
31.188 (63/202) |
4.42E-20 |
MAPK/ERK kinase kinase 3 (MAP3K3)
|
|
31.658 (63/199) |
4.48E-20 |
ERK activator kinase 2 (MEK2)
|
|
30.047 (64/213) |
5.62E-20 |
PAK-1 protein kinase (PAK1)
|
|
28.856 (58/201) |
5.88E-20 |
Serine/threonine-protein kinase D3 (PRKD3)
|
|
32.124 (62/193) |
7.21E-20 |
PKC-delta-interacting protein kinase (RIPK4)
|
|
28.044 (76/271) |
1.02E-19 |
MAP/microtubule affinity-regulating kinase 4 (MARK4)
|
|
27.273 (75/275) |
1.04E-19 |
MEK kinase kinase 4 (MAP4K4)
|
|
28.641 (59/206) |
1.18E-19 |
Serine/threonine-protein kinase PAK 3 (PAK3)
|
|
28.358 (57/201) |
1.29E-19 |
Serine/threonine-protein kinase Nek11 (NEK11)
|
|
27.931 (81/290) |
1.60E-19 |
Protein kinase D (PRKD1)
|
|
31.606 (61/193) |
2.19E-19 |
Ste-20-related kinase (STK39)
|
|
27.798 (77/277) |
2.73E-19 |
Cyclin-dependent kinase 2 (CDK2)
|
|
29.208 (59/202) |
2.88E-19 |
TRAF2 and NCK interacting kinase (TNIK)
|
|
29.126 (60/206) |
2.94E-19 |
Oxidative stress responsive 1 (OXSR1)
|
|
25.938 (83/320) |
4.00E-19 |
Inhibitor of nuclear factor kappa-B kinase alpha (IKKA)
|
|
30.198 (61/202) |
5.33E-19 |
Serine/threonine-protein kinase PAK 6 (PAK6)
|
|
29.798 (59/198) |
6.42E-19 |
Serine/threonine-protein kinase MAK (MAK)
|
|
25.321 (79/312) |
6.44E-19 |
Serine/threonine-protein kinase ICK (CILK1)
|
|
25.234 (81/321) |
7.48E-19 |
NIMA-related kinase 1 (NEK1)
|
|
25.000 (70/280) |
1.21E-18 |
Myosin light chain kinase 3 (MYLK3)
|
|
28.182 (62/220) |
1.22E-18 |
Salt-inducible kinase 1 (SIK1)
|
|
31.088 (60/193) |
1.23E-18 |
MEK kinase kinase 2 (MAP4K2)
|
|
25.389 (49/193) |
1.28E-18 |
Putative serine/threonine-protein kinase SIK1B (SIK1B)
|
|
31.088 (60/193) |
1.30E-18 |
Serine/threonine-protein kinase D2 (PRKD2)
|
|
31.088 (60/193) |
1.32E-18 |
Misshapen-like kinase 1 (MINK1)
|
|
27.941 (57/204) |
1.41E-18 |
Serine/threonine-protein kinase H1 (PSKH1)
|
|
30.481 (57/187) |
1.67E-18 |
STE20-related serine/threonine-protein kinase (SLK)
|
|
30.151 (60/199) |
1.86E-18 |
Serine/threonine-protein kinase Nek10 (NEK10)
|
|
25.817 (79/306) |
2.26E-18 |
Calcium/calmodulin-dependent protein kinase type 1 (CAMK1)
|
|
27.957 (52/186) |
2.47E-18 |
Calcium/calmodulin-dependent protein kinase type 1G (CAMK1G)
|
|
27.807 (52/187) |
2.84E-18 |
Serine/threonine-protein kinase MARK2 (MARK2)
|
|
29.534 (57/193) |
3.00E-18 |
Putative serine/threonine-protein kinase PRKY (PRKY)
|
|
25.561 (57/223) |
3.22E-18 |
SPS1/STE20-related protein kinase YSK4 (YSK4)
|
|
28.000 (56/200) |
3.97E-18 |
Myosin-IIIb (MYO3B)
|
|
31.220 (64/205) |
4.38E-18 |
Serine/threonine-protein kinase MARK1 (MARK1)
|
|
27.064 (59/218) |
5.87E-18 |
PAK-4 protein kinase (PAK4)
|
|
28.283 (56/198) |
6.05E-18 |
TAO kinase 1 (TAOK1)
|
|
32.161 (64/199) |
6.20E-18 |
cAMP-dependent protein kinase catalytic subunit PRKX (PRKX)
|
|
26.733 (54/202) |
1.01E-17 |
Serine/threonine-protein kinase TAO2 (TAOK2)
|
|
31.658 (63/199) |
1.49E-17 |
Microtubule affinity regulating kinase 3 (MARK3)
|
|
28.497 (55/193) |
2.53E-17 |
Cyclin-dependent kinase 7 (CDK7)
|
|
32.110 (70/218) |
4.42E-17 |
Cyclin-dependent kinase-like 3 (CDKL3)
|
|
27.570 (59/214) |
4.84E-17 |
Salt-inducible kinase 2 (SIK2)
|
|
29.534 (57/193) |
5.02E-17 |
Serine/threonine-protein kinase Nek8 (NEK8)
|
|
24.498 (61/249) |
5.22E-17 |
Receptor-interacting serine/threonine-protein kinase 3 (RIPK3)
|
|
26.214 (81/309) |
5.53E-17 |
Serine/threonine-protein kinase PAK 5 (PAK5)
|
|
27.895 (53/190) |
7.59E-17 |
Myosin light chain kinase 2 (MYLK2)
|
|
26.383 (62/235) |
1.30E-16 |
NIMA-related kinase 2 (NEK2)
|
|
27.442 (59/215) |
1.87E-16 |
TAO kinase 3 (TAOK3)
|
|
32.338 (65/201) |
1.90E-16 |
Inhibitor of nuclear factor kappa-B kinase beta (IKKB)
|
|
29.703 (60/202) |
2.04E-16 |
Peripheral plasma membrane protein CASK (CASK)
|
|
28.500 (57/200) |
2.16E-16 |
Calcium/calmodulin-dependent protein kinase type 1D (CAMK1D)
|
|
26.064 (49/188) |
2.36E-16 |
Death-associated protein kinase 3 (DAPK3)
|
|
27.881 (75/269) |
3.47E-16 |
Doublecortin-like kinase 1 (DCLK1)
|
|
28.495 (53/186) |
3.67E-16 |
Protein kinase C theta (PRKCQ)
|
|
28.431 (58/204) |
3.79E-16 |
Calcium/calmodulin-dependent protein kinase type II subunit gamma (CAMK2G)
|
|
28.230 (59/209) |
4.19E-16 |
Putative 3-phosphoinositide-dependent protein kinase 2 (PDPK2P)
|
|
26.786 (60/224) |
4.57E-16 |
Polo-like kinase 4 (PLK4)
|
|
28.054 (62/221) |
5.42E-16 |
Serine/threonine-protein kinase 33 (STK33)
|
|
23.313 (76/326) |
5.53E-16 |
Aurora kinase C (AURKC)
|
|
27.014 (57/211) |
6.00E-16 |
Serine/threonine-protein kinase H2 (PSKH2)
|
|
28.497 (55/193) |
6.23E-16 |
Calcium/calmodulin-dependent protein kinase type II subunit delta (CAMK2D)
|
|
28.796 (55/191) |
7.38E-16 |
Serine/threonine-protein kinase Nek9 (NEK9)
|
|
24.648 (70/284) |
1.02E-15 |
Doublecortin-like kinase 2 (DCLK2)
|
|
27.419 (51/186) |
1.05E-15 |
Phosphoinositide dependent protein kinase-1 (PDPK1)
|
|
26.786 (60/224) |
1.33E-15 |
Myosin-IIIa (MYO3A)
|
|
29.412 (60/204) |
1.43E-15 |
Death-associated protein kinase 1 (DAPK1)
|
|
30.732 (63/205) |
1.51E-15 |
BR serine/threonine kinase 1 (BRSK1)
|
|
27.731 (66/238) |
1.66E-15 |
Cyclin-dependent kinase 9 (CDK9)
|
|
29.952 (62/207) |
2.54E-15 |
Cyclin-dependent kinase 4 (CDK4)
|
|
30.583 (63/206) |
2.69E-15 |
Ribosomal protein S6 kinase alpha-1 (RSK1)
|
|
28.061 (55/196) |
2.73E-15 |
Cyclin-dependent kinase 5 (CDK5)
|
|
31.122 (61/196) |
2.75E-15 |
Dual specificity mitogen-activated protein kinase kinase 3 (MAP2K3)
|
|
26.103 (71/272) |
3.07E-15 |
Serine/threonine-protein kinase WNK4 (WNK4)
|
|
30.457 (60/197) |
3.82E-15 |
Calcium/calmodulin-dependent protein kinase type IV (CAMK4)
|
|
26.540 (56/211) |
4.40E-15 |
Ribosomal protein S6 kinase alpha-6 (RSK6)
|
|
28.571 (56/196) |
4.49E-15 |
BR serine/threonine kinase 2 (BRSK2)
|
|
28.462 (74/260) |
5.25E-15 |
5'-AMP-activated protein kinase catalytic subunit alpha-1 (PRKAA1)
|
|
25.896 (65/251) |
6.50E-15 |
Aurora kinase A (AURKA)
|
|
25.743 (52/202) |
6.58E-15 |
Calcium/calmodulin-dependent protein kinase type II subunit alpha (CAMK2A)
|
|
28.042 (53/189) |
8.04E-15 |
MAPK/MAK/MRK overlapping kinase (MOK)
|
|
30.928 (60/194) |
9.84E-15 |
Cyclin-dependent kinase-like 1 (CDKL1)
|
|
26.154 (51/195) |
1.06E-14 |
STE20-related kinase adapter protein beta (STRADB)
|
|
28.431 (58/204) |
1.56E-14 |
ERK activator kinase 5 (MAP2K5)
|
|
25.100 (63/251) |
1.59E-14 |
Hormonally up-regulated neu tumor-associated kinase (HUNK)
|
|
24.771 (54/218) |
1.74E-14 |
Apoptosis signal-regulating kinase 2 (MAP3K6)
|
|
28.500 (57/200) |
1.75E-14 |
Cyclin-dependent kinase-like 2 (CDKL2)
|
|
27.320 (53/194) |
1.80E-14 |
Microtubule-associated serine/threonine-protein kinase 3 (MAST3)
|
|
29.741 (69/232) |
1.82E-14 |
Cyclin-dependent kinase-like 4 (CDKL4)
|
|
26.667 (52/195) |
1.88E-14 |
Cyclin-dependent kinase 14 (CDK14)
|
|
29.756 (61/205) |
1.96E-14 |
Death-associated protein kinase 2 (DAPK2)
|
|
29.064 (59/203) |
2.20E-14 |
Dual specificity mitogen-activated protein kinase kinase 6 (MAP2K6)
|
|
25.940 (69/266) |
2.46E-14 |
Cyclin-dependent kinase 15 (CDK15)
|
|
28.643 (57/199) |
2.50E-14 |
Aurora kinase B (AURKB)
|
|
24.038 (50/208) |
2.82E-14 |
SIK family kinase 3 (SIK3)
|
|
26.563 (51/192) |
2.97E-14 |
Microtubule-associated serine/threonine-protein kinase 2 (MAST2)
|
|
31.507 (69/219) |
3.03E-14 |
Protein kinase C alpha (PRKCA)
|
|
25.854 (53/205) |
3.36E-14 |
Microtubule-associated serine/threonine-protein kinase 4 (MAST4)
|
|
29.596 (66/223) |
3.51E-14 |
RAC-gamma serine/threonine-protein kinase (AKT3)
|
|
26.872 (61/227) |
3.63E-14 |
Ribosomal protein S6 kinase alpha-2 (RSK2)
|
|
27.041 (53/196) |
3.87E-14 |
cAMP-dependent protein kinase catalytic subunit beta (PRKACB)
|
|
26.471 (54/204) |
4.18E-14 |
Calcium/calmodulin-dependent protein kinase type II subunit beta (CAMK2B)
|
|
27.749 (53/191) |
4.53E-14 |
Microtubule-associated serine/threonine-protein kinase 1 (MAST1)
|
|
30.275 (66/218) |
4.61E-14 |
Cyclin-dependent kinase 17 (CDK17)
|
|
29.949 (59/197) |
4.97E-14 |
SNF-related serine/threonine-protein kinase (SNRK)
|
|
26.482 (67/253) |
6.25E-14 |
Serine/threonine-protein kinase Sgk3 (SGK3)
|
|
27.461 (53/193) |
6.31E-14 |
Tyrosine-protein kinase EIF2AK2 (p68)
|
|
24.091 (53/220) |
7.06E-14 |
Cyclin-dependent kinase-like 5 (CDKL5)
|
|
24.737 (47/190) |
7.27E-14 |
Ribosomal protein S6 kinase alpha-5 (RSK5)
|
|
27.919 (55/197) |
7.51E-14 |
RAC-beta serine/threonine-protein kinase (AKT2)
|
|
24.153 (57/236) |
8.37E-14 |
Serine/threonine-protein kinase NIM1 (NIM1K)
|
|
30.000 (57/190) |
9.54E-14 |
Leucine-rich repeat serine/threonine-protein kinase 1 (LRRK1)
|
|
30.556 (55/180) |
9.56E-14 |
Omphalocele kinase 1 (NUAK1)
|
|
24.490 (48/196) |
9.85E-14 |
Checkpoint kinase-1 (CHK1)
|
|
27.551 (54/196) |
1.29E-13 |
Cyclin-dependent kinase 6 (CDK6)
|
|
28.780 (59/205) |
1.32E-13 |
Rho-associated protein kinase 2 (ROCK2)
|
|
29.949 (59/197) |
1.41E-13 |
IL-1 receptor-associated kinase 1 (IRAK1)
|
|
26.953 (69/256) |
1.77E-13 |
Cyclin-dependent kinase 18 (CDK18)
|
|
30.769 (60/195) |
1.84E-13 |
Activin receptor type IB (ACVR1B)
|
|
33.784 (75/222) |
1.91E-13 |
Serine/threonine-protein kinase PLK3 (PLK3)
|
|
28.718 (56/195) |
1.94E-13 |
Bone morphogenetic protein receptor (BMPR2)
|
|
31.600 (79/250) |
1.94E-13 |
Protein kinase C zeta (PRKCZ)
|
|
27.094 (55/203) |
1.97E-13 |
Ribosomal protein S6 kinase alpha-3 (RSK3)
|
|
28.643 (57/199) |
2.33E-13 |
NUAK family SNF1-like kinase 2 (NUAK2)
|
|
26.154 (51/195) |
2.34E-13 |
Serine/threonine-protein kinase Sgk1 (SGK1)
|
|
30.000 (60/200) |
2.57E-13 |
Obscurin (OBSCN)
|
|
27.419 (51/186) |
2.70E-13 |
Protein kinase C iota (PRKCI)
|
|
26.601 (54/203) |
2.78E-13 |
Ribosomal protein S6 kinase beta-1 (S6K1)
|
|
26.263 (52/198) |
2.79E-13 |
Leucine-rich repeat kinase 2 (LRRK2)
|
|
27.604 (53/192) |
3.16E-13 |
Activin receptor type IIA (ACVR2A)
|
|
30.890 (59/191) |
3.32E-13 |
Striated muscle preferentially expressed protein kinase (SPEG)
|
|
26.733 (54/202) |
3.66E-13 |
Cyclin-dependent kinase 16 (CDK16)
|
|
28.571 (56/196) |
4.18E-13 |
Membrane-associated kinase (PKMYT1)
|
|
27.488 (58/211) |
4.56E-13 |
TGF-beta receptor type I (TGFBR1)
|
|
32.877 (72/219) |
5.21E-13 |
Protein kinase C beta (PRKCB)
|
|
25.258 (49/194) |
5.87E-13 |
Protein kinase C delta (PRKCD)
|
|
23.830 (56/235) |
7.46E-13 |
Mitogen-activated protein kinase kinase kinase 15 (MAP3K15)
|
|
29.353 (59/201) |
7.70E-13 |
cAMP-dependent protein kinase catalytic subunit gamma (PRKACG)
|
|
24.870 (48/193) |
7.74E-13 |
Serine/threonine-protein kinase WNK1 (WNK1)
|
|
29.442 (58/197) |
8.27E-13 |
Maternal embryonic leucine zipper kinase (MELK)
|
|
28.571 (54/189) |
9.43E-13 |
Protein kinase N3 (PKN3)
|
|
26.335 (74/281) |
9.66E-13 |
Citron Rho-interacting kinase (CIT)
|
|
29.756 (61/205) |
9.84E-13 |
Myosin light chain kinase family member 4 (MYLK4)
|
|
27.513 (52/189) |
1.11E-12 |
Extracellular signal-regulated kinase 5 (ERK5)
|
|
25.837 (54/209) |
1.16E-12 |
Serine/threonine-protein kinase STK11 (STK11)
|
|
27.928 (62/222) |
1.20E-12 |
Serine/threonine-protein kinase Chk2 (RAD53)
|
|
25.472 (54/212) |
1.35E-12 |
Serine/threonine-protein kinase SBK1 (SBK1)
|
|
25.000 (48/192) |
1.39E-12 |
cAMP-dependent protein kinase catalytic subunit alpha (PRKACA)
|
|
24.757 (51/206) |
1.65E-12 |
Stress-activated protein kinase JNK1 (JNK1)
|
|
25.434 (88/346) |
1.68E-12 |
PDZ binding kinase (PBK)
|
|
25.833 (62/240) |
1.83E-12 |
Cyclin-dependent kinase 13 (CDK13)
|
|
25.076 (82/327) |
1.84E-12 |
ERK activator kinase 7 (MAP2K7)
|
|
27.143 (76/280) |
2.40E-12 |
Stress-activated protein kinase JNK2 (JNK2)
|
|
25.723 (89/346) |
2.47E-12 |
Protein kinase C gamma (PRKCG)
|
|
26.407 (61/231) |
2.73E-12 |
Ribosomal protein S6 kinase-related protein (RSKR)
|
|
28.125 (54/192) |
2.78E-12 |
Testis-specific serine/threonine-protein kinase 6 (TSSK6)
|
|
26.667 (72/270) |
3.24E-12 |
Stress-activated protein kinase JNK3 (JNK3)
|
|
25.959 (88/339) |
3.94E-12 |
Glycogen synthase kinase-3 alpha (GSK-3A)
|
|
25.381 (50/197) |
5.12E-12 |
Rho-associated protein kinase 1 (ROCK1)
|
|
29.018 (65/224) |
5.25E-12 |
Apoptosis signal-regulating kinase 1 (MAP3K5)
|
|
27.692 (54/195) |
5.59E-12 |
Serine/threonine-protein kinase WNK2 (WNK2)
|
|
28.426 (56/197) |
5.63E-12 |
Activin receptor type IIB (ACVR2B)
|
|
29.730 (55/185) |
7.06E-12 |
5'-AMP-activated protein kinase catalytic subunit alpha-2 (PRKAA2)
|
|
26.020 (51/196) |
7.33E-12 |
Serine/threonine-protein kinase Sgk2 (SGK2)
|
|
26.943 (52/193) |
7.44E-12 |
Polo-like kinase 2 (PLK2)
|
|
25.389 (49/193) |
7.64E-12 |
Serine/threonine-protein kinase NIK (MAP3K14)
|
|
27.225 (52/191) |
1.09E-11 |
G protein-coupled receptor kinase 6 (GRK6)
|
|
27.692 (54/195) |
1.27E-11 |
RAC-alpha serine/threonine-protein kinase (AKT1)
|
|
26.804 (52/194) |
1.43E-11 |
Ribosomal protein S6 kinase alpha-4 (RPS6KA4)
|
|
30.964 (61/197) |
1.63E-11 |
Cyclin-dependent kinase 12 (CDK12)
|
|
25.366 (52/205) |
1.68E-11 |
IL-1 receptor-associated kinase 3 (IRAK3)
|
|
23.675 (67/283) |
1.95E-11 |
Serine/threonine-protein kinase ULK4 (ULK4)
|
|
26.923 (56/208) |
2.08E-11 |
Nik-related protein kinase (NRK)
|
|
24.675 (57/231) |
2.34E-11 |
Protein kinase G1 (PRKG1)
|
|
28.293 (58/205) |
2.41E-11 |
Cyclin-dependent kinase 10 (CDK10)
|
|
29.851 (60/201) |
2.82E-11 |
STE20-related kinase adapter protein alpha (STRADA)
|
|
23.581 (54/229) |
3.04E-11 |
Serine/threonine-protein kinase MRCK gamma (CDC42BPG)
|
|
28.509 (65/228) |
3.17E-11 |
Polo-like kinase 1 (PLK1)
|
|
25.907 (50/193) |
3.34E-11 |
Glycogen synthase kinase-3 beta (GSK-3B)
|
|
27.273 (54/198) |
3.95E-11 |
Serine/threonine-protein kinase 35 (STK35)
|
|
29.500 (59/200) |
4.15E-11 |
Yet another novel kinase 2 (STK32B)
|
|
27.778 (55/198) |
4.23E-11 |
WNK lysine-deficient protein kinase 3 (WNK3)
|
|
28.426 (56/197) |
4.25E-11 |
Cyclin-dependent kinase 11A (CDK11A)
|
|
25.238 (53/210) |
4.56E-11 |
Eukaryotic translation initiation factor 2-alpha kinase 4 (EIF2AK4)
|
|
28.631 (69/241) |
4.98E-11 |
Serine/threonine-protein kinase NLK (NLK)
|
|
27.053 (56/207) |
5.05E-11 |
Serine/threonine-protein kinase 32C (STK32C)
|
|
26.263 (52/198) |
5.27E-11 |
Testis-specific serine/threonine-protein kinase 4 (TSSK4)
|
|
25.000 (54/216) |
5.46E-11 |
Interleukin-1 receptor-associated kinase-like 2 (IRAK2)
|
|
25.837 (54/209) |
5.62E-11 |
Testis-specific serine/threonine-protein kinase 3 (TSSK3)
|
|
25.681 (66/257) |
6.35E-11 |
Cyclin-dependent kinase 11B (CDK11B)
|
|
25.000 (53/212) |
6.83E-11 |
MAPK-activated protein kinase 3 (MAPKAPK3)
|
|
28.141 (56/199) |
7.29E-11 |
Wee1-like protein kinase (WEE1)
|
|
25.735 (70/272) |
9.75E-11 |
Inhibitor of nuclear factor kappa-B kinase subunit epsilon (IKBKE)
|
|
27.861 (56/201) |
9.82E-11 |
Serine/threonine-protein kinase/endoribonuclease IRE2 (ERN2)
|
|
30.412 (59/194) |
1.10E-10 |
Wee1-like protein kinase 2 (WEE2)
|
|
26.421 (79/299) |
1.19E-10 |
Testis-specific serine/threonine-protein kinase 1 (TSSK1B)
|
|
23.661 (53/224) |
1.20E-10 |
Ribosomal protein S6 kinase beta-2 (RPS6KB2)
|
|
24.747 (49/198) |
1.21E-10 |
Homeodomain-interacting protein kinase 4 (HIPK4)
|
|
28.061 (55/196) |
1.24E-10 |
Serine/threonine-protein kinase 32A (STK32A)
|
|
25.641 (50/195) |
1.59E-10 |
Rhodopsin kinase GRK1 (GRK1)
|
|
25.888 (51/197) |
1.69E-10 |
Phosphorylase kinase testis gamma 2 (PHKG2)
|
|
24.878 (51/205) |
2.11E-10 |
Proto-oncogene serine/threonine-protein kinase mos (MOS)
|
|
25.571 (56/219) |
2.12E-10 |
Cyclin-dependent kinase 19 (CDK19)
|
|
25.316 (60/237) |
3.32E-10 |
Mitogen-activated protein kinase 15 (MAPK15)
|
|
26.633 (53/199) |
4.06E-10 |
Calmodulin-dependent kinase II (CAMKK2)
|
|
27.848 (44/158) |
4.37E-10 |
Protein kinase C epsilon (PRKCE)
|
|
24.631 (50/203) |
5.06E-10 |
Protein kinase C eta type (PRKCH)
|
|
25.258 (49/194) |
6.76E-10 |
Beta-adrenergic receptor kinase 1 (ADRBK1)
|
|
28.436 (60/211) |
6.97E-10 |
Serine/threonine-protein kinase 17B (STK17B)
|
|
25.773 (50/194) |
7.05E-10 |
NF-kappa-B-activating kinase (TBK1)
|
|
26.263 (52/198) |
7.69E-10 |
Stress-activated protein kinase 2b (p38 beta)
|
|
23.762 (48/202) |
9.37E-10 |
MAP kinase p38 (MAPK12)
|
|
26.214 (54/206) |
1.02E-09 |
G protein-coupled receptor kinase 5 (GRK5)
|
|
27.041 (53/196) |
2.09E-09 |
Anti-mullerian hormone II receptor (AMHR2)
|
|
28.571 (50/175) |
2.25E-09 |
NDR1 protein kinase (STK38)
|
|
24.055 (70/291) |
2.27E-09 |
Beta-adrenergic receptor kinase 2 (ADRBK2)
|
|
28.436 (60/211) |
2.36E-09 |
NDR2 protein kinase (STK38L)
|
|
23.368 (68/291) |
2.45E-09 |
Dual specificity mitogen-activated protein kinase kinase 4 (MAP2K4)
|
|
26.148 (74/283) |
2.62E-09 |
Testis-specific serine kinase 2 (TSSK2)
|
|
27.152 (41/151) |
3.69E-09 |
Serine/threonine-protein kinase cot (COT)
|
|
22.456 (64/285) |
5.09E-09 |
Mitogen-activated protein kinase 13 (MAPK13)
|
|
24.000 (48/200) |
5.19E-09 |
Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform (PHKG1)
|
|
25.000 (52/208) |
5.99E-09 |
Dual-specificity tyrosine-phosphorylation regulated kinase 3 (DYRK3)
|
|
24.464 (57/233) |
6.71E-09 |
MAPK-activated protein kinase 2 (MAPKAPK2)
|
|
25.676 (57/222) |
8.88E-09 |
Myotonin-protein kinase (DMPK)
|
|
31.053 (59/190) |
8.89E-09 |
Stress-activated protein kinase 2a (p38 alpha)
|
|
24.272 (50/206) |
9.80E-09 |
PAS domain-containing serine/threonine-protein kinase (PASK)
|
|
25.824 (47/182) |
1.01E-08 |
MAP kinase signal-integrating kinase 2 (MKNK2)
|
|
26.020 (51/196) |
1.10E-08 |
CaM-kinase IV kinase (CAMKK1)
|
|
22.764 (56/246) |
1.32E-08 |
Cyclin-dependent kinase 8 (CDK8)
|
|
24.473 (58/237) |
1.47E-08 |
Homeodomain-interacting protein kinase 3 (HIPK3)
|
|
26.154 (51/195) |
1.65E-08 |
Casein kinase II alpha (CSNK2A1)
|
|
27.000 (54/200) |
1.67E-08 |
Protein kinase G2 (PRKG2)
|
|
24.352 (47/193) |
2.03E-08 |
Serine/threonine-protein kinase SBK2 (SBK2)
|
|
25.389 (49/193) |
2.41E-08 |
Extracellular signal-regulated kinase 2 (ERK2)
|
|
27.044 (43/159) |
2.49E-08 |
G protein-coupled receptor kinase 4 (GRK4)
|
|
27.179 (53/195) |
3.69E-08 |
Homeodomain-interacting protein kinase 1 (HIPK1)
|
|
25.888 (51/197) |
3.95E-08 |
Endoplasmic reticulum to nucleus signaling 1 (ERN1)
|
|
26.800 (67/250) |
4.27E-08 |
CaM kinase-like vesicle-associated protein (CAMKV)
|
|
22.995 (43/187) |
5.11E-08 |
TBC domain-containing protein kinase-like protein (TBCK)
|
|
25.434 (44/173) |
5.15E-08 |
Casein kinase II subunit alpha 3 (CSNK2A3)
|
|
26.500 (53/200) |
6.00E-08 |
Extracellular signal-regulated kinase 1 (ERK1)
|
|
28.659 (47/164) |
6.67E-08 |
Protein kinase N2 (PKN2)
|
|
23.902 (49/205) |
6.97E-08 |
PRKR-like endoplasmic reticulum kinase (PERK)
|
|
30.088 (34/113) |
8.76E-08 |
Protein kinase N1 (PKN1)
|
|
25.490 (52/204) |
8.91E-08 |
MAPK-activated protein kinase 5 (MAPKAPK5)
|
|
24.299 (52/214) |
1.01E-07 |
Mitogen-activated protein kinase 4 (MAPK4)
|
|
25.352 (54/213) |
1.04E-07 |
Homeodomain interacting protein kinase 2 (HIPK2)
|
|
25.758 (51/198) |
1.05E-07 |
Casein kinase II alpha prime (CSNK2A2)
|
|
27.000 (54/200) |
1.06E-07 |
Cyclin-dependent kinase 20 (CDK20)
|
|
26.768 (53/198) |
1.25E-07 |
Serine/threonine-protein kinase PDIK1L (PDIK1L)
|
|
34.259 (37/108) |
1.39E-07 |
Cytoplasmic DRAK1 (STK17A)
|
|
22.581 (49/217) |
3.03E-07 |
Dual-specificity tyrosine-phosphorylation regulated kinase 2 (DYRK2)
|
|
25.758 (51/198) |
4.29E-07 |
TGF-beta-stimulated factor 1 (STK16)
|
|
28.293 (58/205) |
4.72E-07 |
Eukaryotic translation initiation factor 2-alpha kinase 1 (EIF2AK1)
|
|
29.358 (32/109) |
7.05E-07 |
Serine/threonine-protein kinase MRCK beta (CDC42BPB)
|
|
25.000 (57/228) |
7.36E-07 |
Rhodopsin kinase GRK7 (GRK7)
|
|
23.431 (56/239) |
1.18E-06 |
Casein kinase I epsilon (CSNK1E)
|
|
23.973 (35/146) |
1.35E-06 |
Tau-tubulin kinase (TTBK1)
|
|
20.532 (54/263) |
1.54E-06 |
Dual-specificity tyrosine-phosphorylation regulated kinase 1B (DYRK1B)
|
|
26.500 (53/200) |
2.68E-06 |
Kalirin (KALRN)
|
|
23.967 (58/242) |
5.02E-06 |
Tau-tubulin kinase 2 (TTBK2)
|
|
20.486 (59/288) |
5.10E-06 |
Serine/threonine-protein kinase greatwall (MASTL)
|
|
25.683 (47/183) |
8.12E-06 |
Titin (TTN)
|
21.939 (43/196) |
8.21E-06 |
CDC42 binding protein kinase alpha (DMPK-like alpha)
|
|
24.229 (55/227) |
8.26E-06 |
Casein kinase I delta (CSNK1D)
|
|
23.288 (34/146) |
8.35E-06 |
Mitogen-activated protein kinase 6 (MAPK6)
|
|
22.330 (46/206) |
8.35E-06 |
Serine/threonine-protein kinase 40 (STK40)
|
|
27.826 (32/115) |
1.58E-05 |
Triple functional domain protein (TRIO)
|
|
24.121 (48/199) |
1.69E-05 |
Dual specificity protein kinase TTK (MPS1)
|
|
24.913 (72/289) |
3.24E-05 |
Dual-specificity tyrosine-phosphorylation regulated kinase 1A (DYRK1A)
|
|
24.623 (49/199) |
3.79E-05 |
Casein kinase I gamma-2 (CSNK1G2)
|
|
24.342 (37/152) |
5.49E-05 |
CDC-like kinase 1 (CLK1)
|
|
24.883 (53/213) |
6.06E-05 |
Serine/threonine-protein kinase 31 (STK31)
|
|
25.786 (41/159) |
7.15E-05 |
Casein kinase I gamma-1 (CSNK1G1)
|
|
25.490 (39/153) |
7.40E-05 |
Serine/threonine-protein kinase tousled-like 2 (TLK2)
|
|
23.153 (47/203) |
8.17E-05 |
Serine/threonine-protein kinase tousled-like 1 (TLK1)
|
|
22.772 (46/202) |
8.51E-05 |
Serine/threonine-protein kinase LATS1 (LATS1)
|
|
22.509 (61/271) |
8.72E-05 |
Casein kinase I gamma-3 (CSNK1G3)
|
|
25.658 (39/152) |
1.36E-04 |
CDC-like kinase 4 (CLK4)
|
|
23.944 (51/213) |
1.65E-04 |
Sugen kinase 110 (SBK3)
|
|
26.400 (33/125) |
2.00E-04 |
Large tumor suppressor homolog 2 (LATS2)
|
|
23.256 (60/258) |
2.36E-04 |
MAPK signal-integrating kinase 1 (MKNK1)
|
|
20.248 (49/242) |
2.36E-04 |
Serine/threonine-protein kinase PINK1, mitochondrial (PINK1)
|
|
30.573 (48/157) |
2.53E-04 |
CDC-like kinase 2 (CLK2)
|
|
24.528 (52/212) |
4.87E-04 |
Dual-specificity tyrosine-phosphorylation regulated kinase 4 (DYRK4)
|
|
22.335 (44/197) |
5.99E-04 |
Casein kinase I alpha (CSNK1A1)
|
|
25.503 (38/149) |
1.00E-03 |
Serine/threonine-protein kinase pim-2 (PIM2)
|
|
25.281 (45/178) |
2.00E-03 |
CDC-like kinase 3 (CLK3)
|
|
22.467 (51/227) |
2.00E-03 |
Nuclear receptor-binding protein 2 (NRBP2)
|
|
25.581 (55/215) |
3.00E-03 |
Click to Show/Hide the Information of Human Similarity Proteins |